1. Home
  2. FISI vs RAPP Comparison

FISI vs RAPP Comparison

Compare FISI & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FISI
  • RAPP
  • Stock Information
  • Founded
  • FISI 1817
  • RAPP 2022
  • Country
  • FISI United States
  • RAPP United States
  • Employees
  • FISI N/A
  • RAPP N/A
  • Industry
  • FISI Major Banks
  • RAPP
  • Sector
  • FISI Finance
  • RAPP
  • Exchange
  • FISI Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • FISI 522.5M
  • RAPP 450.0M
  • IPO Year
  • FISI 1999
  • RAPP 2024
  • Fundamental
  • Price
  • FISI $24.60
  • RAPP $10.92
  • Analyst Decision
  • FISI Buy
  • RAPP Strong Buy
  • Analyst Count
  • FISI 3
  • RAPP 5
  • Target Price
  • FISI $33.00
  • RAPP $35.00
  • AVG Volume (30 Days)
  • FISI 108.0K
  • RAPP 225.8K
  • Earning Date
  • FISI 07-24-2025
  • RAPP 08-07-2025
  • Dividend Yield
  • FISI 5.03%
  • RAPP N/A
  • EPS Growth
  • FISI N/A
  • RAPP N/A
  • EPS
  • FISI N/A
  • RAPP N/A
  • Revenue
  • FISI $108,628,000.00
  • RAPP N/A
  • Revenue This Year
  • FISI $101.16
  • RAPP N/A
  • Revenue Next Year
  • FISI $6.68
  • RAPP N/A
  • P/E Ratio
  • FISI N/A
  • RAPP N/A
  • Revenue Growth
  • FISI N/A
  • RAPP N/A
  • 52 Week Low
  • FISI $17.27
  • RAPP $6.43
  • 52 Week High
  • FISI $29.79
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • FISI 39.93
  • RAPP N/A
  • Support Level
  • FISI $24.41
  • RAPP N/A
  • Resistance Level
  • FISI $26.60
  • RAPP N/A
  • Average True Range (ATR)
  • FISI 0.46
  • RAPP 0.00
  • MACD
  • FISI -0.19
  • RAPP 0.00
  • Stochastic Oscillator
  • FISI 8.68
  • RAPP 0.00

About FISI Financial Institutions Inc.

Financial Institutions Inc operates as a financial holding company, engages in the provision of a wide range of consumer and commercial banking services to individuals, municipalities, and businesses in Western and Central New York. It operates through one segment: The Banking segment which includes all of the company's retail and commercial banking operations.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: